Mass Immunization in Iran and its Challenges 

Discover the challenges faced by Iran in its mass immunization campaign against COVID-19 and how it has successfully reduced the fatality rate. Explore the impact of international cooperation and the obstacles caused by financial restrictions. Find out how Iran is navigating these challenges while ensuring access to medical supplies and supporting affected businesses.

Medriva Newsroom
New Update



Since the government of Iran began a massive immunization campaign, the fatality rate from coronavirus has decreased.


"Today, we have a very high potential to make vaccines in the country and sell them," Iranian President Seyed Ebrahim Rayeesi said in an interview with state television in May, when asked about reopening businesses and schools following a successful vaccination program.

Hundreds of deaths a day from the coronavirus have been reduced to one digit from hundreds by the president's government actions, he said.

All countries and territories are affected by COVID-19, which is a global threat. In late 2019, Wuhan, China, was the first place to report it. As many as 6.9 ml individuals have perished and 538 ml others have been infected.


According to the Iranian foreign ministry, despite Washington's assurances of cooperation in order to supply Iran with drugs through an innovative Swiss payment technique, the US is impeding the process.

Iran's financial resources in other countries have been stopped from being transferred into the Swiss Humanitarian Trade Arrangement, according to former Iranian Foreign Ministry spokesman Seyed Abbas Mousavi (SHTA).

Despite a rise in coronavirus infections and deaths, Washington and its allies were chastised by Iran's First Vice President Mohammad Mokhber in August for implementing banking penalties that prevent the country from purchasing drugs and medical equipment.

He also noted that the lack of medicine and treatment-related concerns have placed a heavy burden on the country's budget, and that careful preparation and efforts are needed to deal with the challenges of businesses affected by COVID-19.

Chat with Dr. Medriva !